27 results
8-K
EX-1.1
NRBO
NeuroBo Pharmaceuticals Inc
8 Nov 22
Neurobo Announces Pricing of $30 Million Underwritten Public Offering and Concurrent Private Placement
5:24pm
taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any … ” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover
424B4
NRBO
NeuroBo Pharmaceuticals Inc
7 Nov 22
Prospectus supplement with pricing info
9:07am
of the holders of common stock, and which could be used to institute a shareholder rights plan, or so-called “poison pill,” that would work to dilute
8-K
EX-10.3
1gkc9fhmawt d9bf
14 Sep 22
Entry into a Material Definitive Agreement
5:11pm
8-K
EX-10.1
6hasaivleaefk2
4 Oct 21
Neurobo Pharmaceuticals Announces $14 Million Registered Direct Offering
4:46pm
8-K
EX-10.1
pu819ce
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-2.1
14j 072h8k7q6h2
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
8-K
EX-10.1
jsc2vs y98k2i1qa
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
424B3
rguvprde oh1eqvi3umo
6 Nov 19
Prospectus supplement
9:15am